ECR Help Desk

Feb 27, 2019
Latest in Clinical News
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
July 30, 2026
Business Handshake Intelligence 400 (1)
Median Technologies signs Canon Medical partnership for eyonis LCS
July 30, 2026
Pexels Thirdman 8940356 (1)
Scottish team designs 10-year sustainability model for preclinical imaging
July 29, 2026
Overview of the hallmarks of cancer and the imaging modalitites that are being used to assess them.
ESMI review maps cancer biology ahead of TOPIM 2026
July 28, 2026
Related Stories
2019 02 27 00 52 1962 2019 02 27 Philips Azurion 20190227004112
Conference
Digital x-ray vendors focus on workflow and efficiency
2019 02 26 23 56 2519 2019 02 27 Nh 1 Cest Thumb
Conference
Liquid biopsy can be game-changer in radiology
2019 02 26 21 00 5734 2019 02 27 Ecr Today Hybrid Thumb
Conference
Be aware of artifacts to improve hybrid imaging outcomes
2019 02 26 21 41 8471 Ecr 2019 400
Conference
AI enables real-time patient dose estimates on CT exams
More in Clinical News
FDG-PET/CT sharpens surveillance after colorectal liver metastasis treatment
By Claudia Tschabuschnig
A Dutch study found that adding metabolic imaging to contrast-enhanced CT improved early detection of local tumor progression after liver ablation or resection, including disease missed by CT alone.
July 30, 2026
Three months after thermal ablation, contrast-enhanced CT (A, B) shows post-treatment changes without clear local progression, while FDG-PET/CECT (C–F) reveals focal uptake suspicious for recurrence.
Median Technologies signs Canon Medical partnership for eyonis LCS
By AuntMinnie.com staff writers
Canon's subsidiary Olea Medical will leverage its CT imaging platform to support distribution of Median's software.
July 30, 2026
Business Handshake Intelligence 400 (1)
Scottish team designs 10-year sustainability model for preclinical imaging
By Claudia Tschabuschnig
A Scottish team has designed a theoretical 10-year strategy for keeping a multimodal preclinical imaging facility financially viable, operationally resilient, environmentally responsible, and accessible to researchers.
July 29, 2026
Pexels Thirdman 8940356 (1)
ESMI review maps cancer biology ahead of TOPIM 2026
By Claudia Tschabuschnig
Ahead of TOPIM 2026, a new Nature Reviews Cancer article explores how molecular imaging can reveal the biological processes driving tumor growth, resistance, and immune evasion.
July 28, 2026
Overview of the hallmarks of cancer and the imaging modalitites that are being used to assess them.
ITM launches new oncology therapeutics division
By AuntMinnie.com staff writers
Lumara Bio will focus resources toward commercial readiness for ITM's lead drug candidate, lutetium-177 (Lu-177) edotreotide (ITM-11).
July 27, 2026
Lumara
Societies host events for MR Safety Week
By AuntMinnie.com staff writers
Observances trace to the 2001 death of Michael Colombini.
July 27, 2026
Safety
SPECT/CT viable over PET/CT for high-risk prostate cancer staging
By Will Morton
Considering its broader accessibility, Tc-99m MIP-1404 CZT SPECT/CT may represent a practical alternative for primary staging.
July 24, 2026
Maximum intensity projection of Ga-68 PSMA-11 PET/CE-CT (A), Tc-99m MIP-1404 CZT SPECT/CT (B) and Tc-99m HDP CZT SPECT/CT (C) imaging. Ga-68 PSMA-11 PET/CE-CT and Tc-99m MIP-1404 CZT SPECT/CT showing tracer uptake in lymph nodes below the iliac bifurcation and above, paraaortic and left supraclavicular, bone uptake in the right proximal femur and right scapula (arrows). Tc-99m HDP CZT SPECT/CT did not show any uptake suspicious for metastatic disease. No sclerotic lesions suspicious of metastases were detected by the CT component in any of the studies. Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (D) and Tc-99m MIP-1404 CZT SPECT/CT (E) showing uptake in lymph nodes in the left pelvic area below the iliac bifurcation (arrows). Fusion axial imaging of Ga-68 PSMA-11 PET/CE-CT (F) and Tc-99m MIP-1404 CZT SPECT/CT (G) showing uptake in the right proximal femur, not detected by Tc-99m HDP CZT SPECT/CT (H), (arrows).
Wellumio nabs $9.75M for portable stroke imaging device
By AuntMinnie.com staff writers
Axana is a portable, battery-powered brain imaging device that delivers MRI-based stroke assessment at the point of care.
July 23, 2026
Wellumio co-founders Dr Shieak Tzeng and Dr Sergei Obruchkov with the Axana portable stroke detection device.
Gender disparities persist in radiology despite progress, ESR survey finds
By Claudia Tschabuschnig
Women were far more likely than men to view gender as a career disadvantage, while differences between European regions suggest opportunities for improvement.
July 23, 2026
Pexels Cristian Rojas 8460378
CT dose, not FDG, drives chromosome damage during PET/CT
By Claudia Tschabuschnig
The findings suggest that standard-dose CT should be reserved for clearly justified diagnostic indications.
July 22, 2026
New research suggests the CT component of PET/CT, rather than the FDG tracer, is associated with measurable chromosome damage.
Are chest x-rays useful in children with recurrent wheezing?
By Will Morton
Recurrent wheezing affects roughly half of all children under three years old.
July 22, 2026
Preschoolers
Spectrum Dynamics expands Veriton SPECT/CT line
By AuntMinnie.com staff writers
The company has unveiled an all-energy enhancement for its CT-400 series digital SPECT/CT scanner.
July 20, 2026
Veriton CT 400 Series digital SPECT/CT scanner with all-energy enhancement.
Page 1 of 1328
Next Page